Interventions to increase adherence to medications for tobacco dependence

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 2, 2015, Pages

  Hollands, Gareth J ^a   Mcdermott, Máirtín S ^b   Lindson Hawley, Nicola ^c   Vogt, Florian ^d   Farley, Amanda ^e   Aveyard, Paul ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NORTRIPTYLINE; VARENICLINE; BENZAZEPINE DERIVATIVE; NICOTINIC AGENT; QUINOXALINE DERIVATIVE;

ANXIETY; CLINICAL EFFECTIVENESS; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; MEDICAL INFORMATION; NICOTINE REPLACEMENT THERAPY; PATIENT COMPLIANCE; PERCEPTION; PRIORITY JOURNAL; PROBLEM SOLVING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; RISK ASSESSMENT; RISK FACTOR; RISK OF BIAS; SENSITIVITY ANALYSIS; SMOKING CESSATION; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE; TREATMENT DURATION; DRUG COMBINATION; MEDICATION COMPLIANCE; META ANALYSIS; PROCEDURES; STATISTICS AND NUMERICAL DATA; TOBACCO USE DISORDER;

BENZAZEPINES; BUPROPION; DRUG THERAPY, COMBINATION; HUMANS; MEDICATION ADHERENCE; NICOTINIC AGONISTS; NORTRIPTYLINE; QUINOXALINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 84934343264     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009164.pub2     Document Type: Review

References (62)

1. Chan SSC, Leung DYP, Abdullah ASM, Lo SST, Yip AWC, Kok W-M, Ho S-Y, Lam T-H. Smoking-Cessation and Adherence Intervention Among Chinese Patients with Erectile Dysfunction. American Journal of Preventive Medicine 2010;39(3):251-258.
2. Chan SSC, Leung DYP, Abdullah ASM, Wong VT, Hedley AJ, Lam T-H. A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking. Addiction 2011;106:1155-1163.
3. Hollands GJ, Sutton S, McDermott M, Marteau TM, Aveyard P. Adherence to and consumption of nicotine replacement therapy and the relationship with abstinence within a smoking cessation trial in primary care. Nicotine & Tobacco Research 2013;15(9):1537-1544.
4. Marteau TM, Aveyard P, Munafò MR, Prevost AT, Hollands GJ, Armstrong D, et al. Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial. PLoS ONE 2012;7(4):e35249.
5. Marteau TM, Munafò MR, Aveyard P, Hill C, Whitwell S, Willis TA, Crockett RA, Hollands GJ, Johnstone EC, Wright AJ, Prevost AT, Armstrong D, Sutton S, Kinmonth AL. Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence. BMC Public Health 2010;10(1):680.
6. Mooney M, Babb D, Jensen J, Hatsukami D. Interventions to increase use of nicotine gum: A randomized, controlled, single-blind trial. Nicotine & Tobacco Research 2004;7(4):565-579.
7. Mooney M, Green C, Hatsukami D. Nicotine self-administration: cigarette versus nicotine gum diurnal topography. Human Psychopharmacology 2006;21(8):539-548.
8. Mooney ME, Sayre SL, Hokanson PS, Stotts AL, Schmitz JM. Adding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion: A replication and extension study. Addictive Behaviors 2007;32:875-880.
9. Nollen NL, Sanderson Cox L, Nazir N, Ellerbeck EF, Owen A, Pankey S, Thompson N, Ahluwalia JS. A Pilot Clinical Trial of Varenicline for Smoking Cessation in Black Smokers. Nicotine & Tobacco Research 2011;13(9):868-873.
10. Schmitz JM, Sayre SL, Stotts AL, Rothfleisch J, Mooney ME. Medication Compliance During a Smoking Cessation Clinical Trial: A Brief Intervention Using MEMS Feedback. Journal of Behavioral Medicine 2005;28(2):139-147.
11. Smith SS, Keller PA, Kobinsky KH, Baker TB, Fraser DL, et al. Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant. Nicotine & Tobacco Research 2013;15(3):718-28.
12. Aveyard P, Brown K, Saunders C, Alexander A, Johnstone E, Munafo MR, Murphy M. Weekly versus basic smoking cessation support in primary care: a randomised controlled trial. Thorax 2007;62:898-903.
13. Bansal-Travers M, Cummings KM, Hyland A, Brown A, Celestino P. Educating smokers about their cigarettes and nicotine medications. Health Education Research 2010;25(4):678-686.
14. Berlin I, Jacob N, Coudert M, Perriot J, Schultz L, Rodon N. Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS trial - a randomized study in smokers with medical comorbidities. Addiction 2011;106(4):833-843.
15. Bock BC, Papandonatos GD, de Dios MA, Abrams DB, Azam MM, Fagan M, Sweeney PJ, Stein MD, Niaura R. Tobacco Cessation Among Low-Income Smokers: Motivational Enhancement and Nicotine Patch Treatment. Nicotine & Tobacco Research 2014;16(4):413-422.
16. Brendryen H, Kraft P. Happy Ending: a randomized controlled trial of a digital multi-media smoking cessation intervention. Addiction 2008;103:478-484.
17. Buchanan LM, El-Banna M, White A, Moses S, Siedlik C, Wood M. An exploratory study of multicomponent treatment intervention for tobacco dependency. Journal of Nursing Scholarship 2004;36(4):324-330.
18. Gariti P, Lynch K, Alterman A, Kampman K, Xie H, Varillo K. Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking. Journal of Substance Abuse Treatment 2009;37(3):247-255.
19. ICRFGPRG . Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. BMJ 1993;306:1304-1308.
20. ICRFGPRG . Randomised trial of nicotine patches in general practice: results at one year. BMJ 1994;308:1476-7.
21. Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS & Behavior 2009;13(3):545-554.
22. Lando HA, Kalb EA, McGovern PG. Behavioral self-help materials as an adjunct to nicotine gum. Addictive Behaviors 1988;13(2):181-184.
23. Lifrak P, Gariti P, Alterman A, McKay J, Volpicelli J, Sparkman T, O'Brien C. Results of two levels of adjunctive treatment used with the nicotine patch. The American Journal on Addictions 1997;6(2):93-98.
24. Okuyemi KS, Thomas JL, Hall S, Nollen NL, Richter KP, Jeffries SK Caldwell AR, Ahluwalia JS. Smoking cessation in homeless populations: a pilot clinical trial. Nicotine & Tobacco Research 2006;8(5):689-699.
25. Okuyemi KS, Goldade K, Whembolua GL, Thomas JL, Eischen S, Sewali B, Guo H, Connett JE, Grant J, Ahluwalia JS, Resnicow K, Owen G, Gelberg L, Des Jarlais D. Motivational Interviewing to Enhance Nicotine Patch Treatment for Smoking Cessation among Homeless Smokers: A Randomized Controlled Trial. Addiction 2013;108:1136-1144.
26. Raupach T, Shahab L, Eimer S, Puls M, Hasenfuss G, Andreas S. Increasing the use of nicotine replacement therapy by a simple intervention: an exploratory trial. Substance Use & Misuse 2010;45(3):403-413.
27. Rigotti NA, Japuntich S, Regan S, Kelley JH, Chang Y, Reyen M, Viana JC, Park ER. Levy D, Korotkin M, Streck J, Singer DE. Promoting smoking cessation after hospital discharge: The helping hand randomized controlled comparative effectiveness trial. Journal of General Internal Medicine 2013;28:S160.
28. Shaughnessy AF, Davis RE, Reeder CE. Nicotine Chewing Gum: Effectiveness and theInfluence of Patient Education in a Family Practice. The Journal of Family Practice 1987;25(3):266-9.
29. Shiffman S, Paty JA, Rohay JM, Di Marino ME, Gitchell J. The Efficacy of Computer-Tailored Smoking Cessation Material as a Supplement to Nicotine Polacrilex Gum Therapy. Archives of Internal Medicine 2000;160:1675-1681.
30. Strecher VJ, Shiffman S, West R. Randomized controlled trial of a web-based computer-tailored smoking cessation program as a supplement to nicotine patch therapy. Addiction 2005;100(5):682-8.
31. Swan GE, McClure JB, Jack LM Zbikowski SM, Javitz HS, Catz SL, Deprey M, Richards J, McAfee TA. Behavioral counseling and varenicline treatment for smoking cessation. American Journal of Preventive Medicine 2010;38(5):482-490.
32. Tønnessen P, Mikkelsen K, Bremann L. Nurse-Conducted Smoking Cessation in Patients With COPD Using Nicotine Sublingual Tablets and Behavioral Support. Chest 2006;130:334-342.
33. Willemsen MC, Wiebing M, Van Emst A, Zeeman G. Helping smokers to decide on the use of efficacious smoking cessation methods: a randomized controlled trial of a decision aid. Addiction 2006;101(3):441-449.
34. Applegate BW, Raymond C, Collado-Rodriguez A, Riley WT, Schneider NG. Improving adherence to nicotine gum by SMS text messaging: a pilot study. Society for Research on Nicotine and Tobacco 13th Annual Meeting February 21-24, Austin, Texas. 2007.
35. Yuhongxia L. The compliance of varenicline usage and the smoking abstinence rate via mobile phone text messaging combine with varenicline: A single-blind, randomised control trial.. Respirology. Conference publication: 16th Congress of the Asian Pacific Society of Respirology Shanghai China. 2011;16:46-7.
36. Evaluation of Treatments to Improve Smoking Cessation Medication Adherence. Ongoing study June 2010.
37. Improving Adherence to Smoking Cessation Medication Among PLWHA (HIV). Ongoing study March 2013.
38. Burns EK, Levinson AH. Discontinuation of Nicotine Replacement Therapy Among Smoking-Cessation Attempters. American Journal of Preventive Medicine 2008;34:212-215.
39. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD006103.pub6]
40. Cheong YS, Ahn SH. Effect of Multi-modal Interventions for Smoking Cessation in a University Setting: A Short Course of Varenicline, Financial Incentives, E-mail and Short Message Service. Korean Journal of Family Medicine 2010;31:355-360.
41. Davis R, Campbell R, Hildon Z, Hobbs L, Michie S. Theories of behaviour and behaviour change across the social and behavioural sciences: a scoping review. Health Psychology Review 2014. [DOI: DOI:10.1080/17437199.2014.941722]
42. Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Archives of Internal Medicine 1999;159:2033-2038.
43. Hammond D, McDonald PW, Fong GT, Borland R. Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour. Addiction 2004;99:1042-1048.
44. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD000011.pub3]
45. Hays JT, Leischow SJ, Lawrence D, Lee TC. Adherence to treatment for tobacco dependence: Association with smoking abstinence and predictors of adherence. Nicotine & Tobacco Research 2010;12(6):574-81.
46. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.10 [updated March 2011]. The Cochrane Collaboration, 2011.
47. Hollands GJ, Sutton S, McDermott M, Marteau TM, Aveyard P. Adherence to and consumption of nicotine replacement therapy and the relationship with abstinence within a smoking cessation trial in primary care. Nicotine & Tobacco Research 2013;15(9):1537-44.
48. Hollands GJ, Shemilt I, Marteau TM, Jebb SA, Kelly MP, Nakamura R, Suhrcke M, Ogilvie D. Altering micro-environments to change population health behaviour: towards an evidence base for choice architecture interventions. BMC Public Health 2013;13:1218.
49. Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD000031.pub4]
50. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD001292.pub2]
51. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959;22:719-748.
52. Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, Eccles MP, Cane J, Wood CE. The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered Techniques: Building an International Consensus for the Reporting of Behavior Change Interventions. Annals of Behavioral Medicine 2013;46(1):81-95.
53. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, Agoritsas T, Mistry N, Iorio A, Jack S, Sivaramalingam B, Iserman E, Mustafa RA, Jedraszewski D, CotoiC, Haynes RB. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD000011.pub4.]
54. Raupach T, Brown J, Herbec A, Brose L, West R. A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success. Addiction 2014;109(1):35-43.
55. Reda AA, Kotz D, Evers SM, van Schayck CP. Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database of Systematic Reviews 2012, Issue 6. [DOI: 10.1002/14651858.CD004305.pub4]
56. Shiffman S. Use of more nicotine lozenges leads to better success in quitting smoking. Addiction 2007;102:809-814.
57. Shiffman S, Sweeney ST, et al. Relationship between adherence to daily nicotine patch use and treatment efficacy: Secondary analysis of a 10 week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers. Clinical Therapeutics 2008;30:1852-1858.
58. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001007.pub2]
59. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD000146.pub4]
60. Stead LF, Lancaster T. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD009670.pub2]
61. Stead LF, Hartmann-Boyce J, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews 2013, Issue 8.
62. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000;320:1574-7.